{"pmid":32427357,"title":"Encephalopathy in patients with COVID-19: 'Causality or coincidence?'","text":["Encephalopathy in patients with COVID-19: 'Causality or coincidence?'","The main tropism of the novel coronavirus disease 2019 (COVID-19) is respiratory. Increasing evidences show that SARS-CoV-2 is not always confined to the respiratory tract but can also invade the central nervous system (CNS) and induce neurological diseases. We report two cases illustrating this phenomenon. This article is protected by copyright. All rights reserved.","J Med Virol","Zayet, Souheil","Ben Abdallah, Yousri","Royer, Pierre-Yves","Toko-Tchiundzie, Lynda","Gendrin, Vincent","Klopfenstein, Timothee","32427357"],"abstract":["The main tropism of the novel coronavirus disease 2019 (COVID-19) is respiratory. Increasing evidences show that SARS-CoV-2 is not always confined to the respiratory tract but can also invade the central nervous system (CNS) and induce neurological diseases. We report two cases illustrating this phenomenon. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zayet, Souheil","Ben Abdallah, Yousri","Royer, Pierre-Yves","Toko-Tchiundzie, Lynda","Gendrin, Vincent","Klopfenstein, Timothee"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427357","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26027","keywords":["coronavirus","nervous system","sars coronavirus"],"topics":["Case Report"],"weight":1,"_version_":1667352728741871616,"score":9.490897,"similar":[{"pmid":32104915,"title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","text":["The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure.","J Med Virol","Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu","32104915"],"abstract":["Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure."],"journal":"J Med Virol","authors":["Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104915","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25728","keywords":["cell susceptibility","coronavirus","dissemination","nervous system"],"locations":["Wuhan","China","SARS-CoV"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490791788544,"score":172.80511},{"pmid":32293714,"title":"Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.","text":["Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.","There has been a global outbreak of coronavirus disease 2019 (COVID-19) since December 2019. In clinical practice, not only fever and respiratory tract symptoms but also multiple organ symptoms are observed in patients diagnosed with COVID-19. Herein, we report a rare case of a patient diagnosed with COVID-19 who manifested with concomitant neurological symptoms. The patient developed fever and respiratory symptoms at disease onset, followed by muscle soreness, and subsequently altered consciousness and psychiatric symptoms, with positive signs based on neurological examination. The patient tested positive for the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) nucleic acid (throat swab). Further, chest computed tomography (CT) revealed typical COVID-19 findings, and head CT did not reveal significant abnormalities. The patient recovered after treatment and was discharged. This rare case indicates that SARS-CoV-2 can invade the central nervous system, thus causing neurological symptoms and signs. This article is protected by copyright. All rights reserved.","J Med Virol","Yin, Rong","Feng, Wei","Wang, Tonghui","Chen, Gang","Wu, Tao","Chen, Dongrui","Lv, Tangfeng","Xiang, Dawei","32293714"],"abstract":["There has been a global outbreak of coronavirus disease 2019 (COVID-19) since December 2019. In clinical practice, not only fever and respiratory tract symptoms but also multiple organ symptoms are observed in patients diagnosed with COVID-19. Herein, we report a rare case of a patient diagnosed with COVID-19 who manifested with concomitant neurological symptoms. The patient developed fever and respiratory symptoms at disease onset, followed by muscle soreness, and subsequently altered consciousness and psychiatric symptoms, with positive signs based on neurological examination. The patient tested positive for the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) nucleic acid (throat swab). Further, chest computed tomography (CT) revealed typical COVID-19 findings, and head CT did not reveal significant abnormalities. The patient recovered after treatment and was discharged. This rare case indicates that SARS-CoV-2 can invade the central nervous system, thus causing neurological symptoms and signs. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yin, Rong","Feng, Wei","Wang, Tonghui","Chen, Gang","Wu, Tao","Chen, Dongrui","Lv, Tangfeng","Xiang, Dawei"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293714","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25888","keywords":["covid-19","meningitis","neurological symptoms"],"topics":["Case Report"],"weight":1,"_version_":1666138494348558336,"score":164.4223},{"pmid":32401352,"title":"Update on the neurology of COVID-19.","text":["Update on the neurology of COVID-19.","Though infection with the SARS-CoV2 virus predominantly manifests in the lung as an interstitial pneumonia (\"ground glass opacities\"), there is increasing evidence that the virus invades all compartments of the body, particularly the eyes, heart, skin, kidneys, and the central nervous system(CNS).(1) This article is protected by copyright. All rights reserved.","J Med Virol","Finsterer, Josef","Stollberger, Claudia","32401352"],"abstract":["Though infection with the SARS-CoV2 virus predominantly manifests in the lung as an interstitial pneumonia (\"ground glass opacities\"), there is increasing evidence that the virus invades all compartments of the body, particularly the eyes, heart, skin, kidneys, and the central nervous system(CNS).(1) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Finsterer, Josef","Stollberger, Claudia"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401352","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jmv.26000","keywords":["sars-cov2","brain","cerebrospinal fluid","meningitis","neurology"],"weight":0,"_version_":1666714494863147008,"score":160.55278},{"pmid":32458578,"title":"COVID-19 encephalopathy masquerading as substance withdrawal.","text":["COVID-19 encephalopathy masquerading as substance withdrawal.","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), first identified in December 2019 in Wuhan, China, is the virus responsible for the current pandemic known as COVID-19. We report the case of a patient with past medical history of substance abuse who presented with suspected drug overdose. He was agitated and altered in the emergency room and he was treated with benzodiazepines for his agitation. He was admitted for substance withdrawal, however his encephalopathy did not improve and he developed choreiform movements. Metabolic, infectious, and rheumatologic workup was negative until he subsequently tested positive for COVID-19. An MRI was performed which showed multiple focal enhancing lesions primarily affecting the bilateral medial putamen and left cerebellum along with subcortical lesions suggesting COVID-19 encephalopathy. He was given glucocorticoids and his mentation and choreiform movements improved. While neurologic presentations are increasingly becoming more common, encephalopathy with choreiform movements appears to be a rare manifestation of SARS-CoV-2, and may be due to direct viral invasion or, more likely, autoimmune mediated toxicity precipitated by the initial viral infection This article is protected by copyright. All rights reserved.","J Med Virol","Byrnes, Sean","Bisen, Maneesh","Syed, Baseer","Huda, Syed","Siddique, Zaid","Sampat, Parth","Russo, Ronald","Oueida, Zaher","Johri, Geetanjali","Dargon, Ian","32458578"],"abstract":["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), first identified in December 2019 in Wuhan, China, is the virus responsible for the current pandemic known as COVID-19. We report the case of a patient with past medical history of substance abuse who presented with suspected drug overdose. He was agitated and altered in the emergency room and he was treated with benzodiazepines for his agitation. He was admitted for substance withdrawal, however his encephalopathy did not improve and he developed choreiform movements. Metabolic, infectious, and rheumatologic workup was negative until he subsequently tested positive for COVID-19. An MRI was performed which showed multiple focal enhancing lesions primarily affecting the bilateral medial putamen and left cerebellum along with subcortical lesions suggesting COVID-19 encephalopathy. He was given glucocorticoids and his mentation and choreiform movements improved. While neurologic presentations are increasingly becoming more common, encephalopathy with choreiform movements appears to be a rare manifestation of SARS-CoV-2, and may be due to direct viral invasion or, more likely, autoimmune mediated toxicity precipitated by the initial viral infection This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Byrnes, Sean","Bisen, Maneesh","Syed, Baseer","Huda, Syed","Siddique, Zaid","Sampat, Parth","Russo, Ronald","Oueida, Zaher","Johri, Geetanjali","Dargon, Ian"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458578","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26065","keywords":["coronavirus","immune responses","sars coronavirus","virus classification"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Benzodiazepines"],"topics":["Case Report"],"weight":1,"_version_":1668141322622468096,"score":159.27608},{"pmid":32329044,"title":"Neurological complications of coronavirus and COVID-19.","text":["Neurological complications of coronavirus and COVID-19.","INTRODUCTION: Clinical and experimental studies have shown that the coronavirus family has a certain tropism for the central nervous system. Seven types of coronavirus can infect humans. DEVELOPMENT: Coronaviruses are not always confined to the respiratory tract, and under certain conditions they can invade the central nervous system and cause neurological pathologies. The potential for neuroinvasion is well documented in most human coronaviruses (OC-43, 229E, MERS and SARS) and in some animal coronaviruses (porcine haemagglutinating encephalomyelitis coronavirus). Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well as cases of encephalopathy, encephalitis, necrotising haemorrhagic encephalopathy, stroke, epileptic seizures, rhabdomyolysis and Guillain-Barre syndrome, associated with SARS-CoV-2 infection. CONCLUSIONS: Future epidemiological studies and case records should elucidate the real incidence of these neurological complications, their pathogenic mechanisms and their therapeutic options.","Rev Neurol","Carod-Artal, F J","32329044"],"abstract":["INTRODUCTION: Clinical and experimental studies have shown that the coronavirus family has a certain tropism for the central nervous system. Seven types of coronavirus can infect humans. DEVELOPMENT: Coronaviruses are not always confined to the respiratory tract, and under certain conditions they can invade the central nervous system and cause neurological pathologies. The potential for neuroinvasion is well documented in most human coronaviruses (OC-43, 229E, MERS and SARS) and in some animal coronaviruses (porcine haemagglutinating encephalomyelitis coronavirus). Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well as cases of encephalopathy, encephalitis, necrotising haemorrhagic encephalopathy, stroke, epileptic seizures, rhabdomyolysis and Guillain-Barre syndrome, associated with SARS-CoV-2 infection. CONCLUSIONS: Future epidemiological studies and case records should elucidate the real incidence of these neurological complications, their pathogenic mechanisms and their therapeutic options."],"journal":"Rev Neurol","authors":["Carod-Artal, F J"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329044","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.33588/rn.7009.2020179","topics":["Diagnosis","Treatment","Mechanism"],"weight":1,"_version_":1666138494599168000,"score":156.81395}]}